摘要: The first goal of therapy is the control gastric acid hypersecretion using PPIs or high-dose H2R antagonists. diagnosis Multiple Endocrine Neoplasia (MEN I) should be established early in disease. Localization gastrinoma tumor performed a combination endoscopic ultrasonography (EUS), somatostatin receptor scintigraphy (SRS), and computerized tomography (CT), Magnetic Resonance Imaging (MRI). Surgical resection sporadic ZES to attempt cure tumor. Surgery, hormonal, chemotherapy, embolization therapeutic OctreoScan considered patients with metastatic
springer.com
sci-hub.se 参考文章(45)
Hirschowitz Bi, Zollinger-Ellison syndrome: pathogenesis, diagnosis, and management. The American Journal of Gastroenterology. ,vol. 92, ,(1997)
David C. Metz, Joseph R. Pisegna, Vitaly A. Fishbeyn, Richard V. Benya, Kathryn M. Feigenbaum, Pamela D. Koviack, Robert T. Jensen, Currently used doses of omeprazole in Zollinger-Ellison syndrome are too high. Gastroenterology. ,vol. 103, pp. 1498- 1508 ,(1992) , 10.1016/0016-5085(92)91170-9
Carl L. Berg, M. Michael Wolfe, Zollinger–Ellison Syndrome Medical Clinics of North America. ,vol. 75, pp. 903- 921 ,(1991) , 10.1016/S0025-7125(16)30420-5
Christian Prinz, Masayoshi Kajimura, David R. Scott, Frederic Mercier, Herbert F. Helander, George Sachs, Histamine secretion from rat enterochromaffinlike cells Gastroenterology. ,vol. 105, pp. 449- 461 ,(1993) , 10.1016/0016-5085(93)90719-S
Joseph R. Pisegna, Grace G. Slimak, John L. Doppman, Doris B. Strader, David C. Metz, Richard V. Benya, Murray Orbuch, Vitaly A. Fishbeyn, Douglas L. Fraker, Jeffrey A. Norton, Paul N. Maton, Robert T. Jensen, An evaluation of human recombinant α interferon in patients with metastatic gastrinoma Gastroenterology. ,vol. 105, pp. 1179- 1183 ,(1993) , 10.1016/0016-5085(93)90965-F
R. Lebtahi, D. Le Guludec, L. Sarda, D. Daou, Y. Petegnief, M. Mignon, M. Faraggi, G. Cadiot, Clinical Impact of Somatostatin Receptor Scintigraphy in the Management of Patients with Neuroendocrine Gastroenteropancreatic Tumors The Journal of Nuclear Medicine. ,vol. 38, pp. 853- 858 ,(1997)
Joseph R. Pisegna, Jeffrey A. Norton, Grace G. Slimak, David C. Metz, Paul N. Maton, Jerry D. Gardner, Robert T. Jensen, Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome. Gastroenterology. ,vol. 102, pp. 767- 778 ,(1992) , 10.1016/0016-5085(92)90157-T
AARON I. VINIK, Controversies in the Management of ZollingerEllison Syndrome Annals of Internal Medicine. ,vol. 105, pp. 956- 959 ,(1986) , 10.7326/0003-4819-105-6-956
JAMES C. THOMPSON, BEVERLY G. LEWIS, ISIDORO WIENER, COURTNEY M. TOWNSEND, The Role of Surgery in the Zollinger-Ellison Syndrome Annals of Surgery. ,vol. 197, pp. 594- 607 ,(1983) , 10.1097/00000658-198305000-00014
Paul N. Maton, Zollinger-Ellison Syndrome Recognition and Management of Acid Hypersecretion Drugs. ,vol. 52, pp. 33- 44 ,(1996) , 10.2165/00003495-199652010-00003